Segment Data

3 Months Ended

Dec. 31, 2016

Segment Reporting [Abstract]

Segment Data

Segment Data

The Company's organizational structure is based upon two principal business segments: BD Medical (“Medical”) and BD Life Sciences (“Life Sciences”). These segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services. The Company evaluates performance of its business segments and allocates resources to them primarily based upon operating income. Segment operating income represents revenues reduced by product costs and operating expenses. As more fully discussed in Note 9, the Company sold a 50.1% controlling financial interest in its Respiratory Solutions business, a component of the Medical segment, in October 2016. This transaction did not meet the criteria established for reporting discontinued operations and as such, the prior-year period included $208 million of revenues which did not occur in the current-year period.

Financial information for the Company’s segments was as follows:

	Three Months Ended December 31,
(Millions of dollars)	2016			2015
Revenues (A)
Medical	$	1,964		$	2,054
Life Sciences	958			933
Total Revenues	$	2,922		$	2,986
Income Before Income Taxes
Medical	$	548		$	465
Life Sciences	198			202
Total Segment Operating Income	747			667
Acquisitions and other restructurings	(87		)	(121		)
Net interest expense	(89		)	(91		)
Other unallocated items (B)	121			(189		)
Income Before Income Taxes	$	692		$	266

(A) Intersegment revenues are not material.

(B) Primarily comprised of foreign exchange, corporate expenses, and share-based compensation expense. The amount for the three months ended December 31, 2016 also included a $336 million reversal of certain reserves related to an appellate court decision which, among other things, reversed an unfavorable antitrust judgment in the RTI case. Additional disclosures regarding this legal matter are provided Note 5.

Revenues by geographic areas were as follows:

	Three Months Ended December 31,
(Millions of dollars)	2016		2015
Revenues
United States	$	1,630	$	1,691
International	1,292		1,295
Total Revenues	$	2,922	$	2,986